HUDSON, MA — (Marketwire) — 01/02/13 — has introduced a new for handling strip metal coils which combines powered lifting and tilting with suction pads that prevent the material from telescoping.The is a compact unit which lets an operator pick up a thin strip metal coil from the top surface, keeping the center hole unobstructed, and then manipulate and load it onto a mandrel. Featuring fully adjustable and lockable power tilting, controlled by a joystick, the are configured to prevent t
NEW BEDFORD, MA — (Marketwire) — 01/02/13 — offers a new prototype program for and other applied graphic products. The program features a flat fee for 10 pieces and rapid delivery.The provides product designers with a finished , decal, nameplate, or overlay from their standard graphic software files within 3-5 days, depending upon part complexity. Digitally printed on a selection of substrates with textures, windows, and various adhesive types, they are laser cut and can include custom sh
VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 12/31/12 — Symax Lift (Holdings) Co. Ltd. (TSX VENTURE: SYL) ("Symax" or the "Company"), is pleased to announce that it has incorporated a new subsidiary, Symax Stairlift Co., Ltd., under the British Columbia Business Corporations Act. This new subsidiary has been incorporated for the purpose of: (i) designing and manufacturing, directly or indirectly through Symax affiliates, chairlift technology and related products for inst
LAKE FOREST, CA — (Marketwire) — 12/27/12 — TRIMEDYNE, INC. ("Trimedyne") (OTCBB: TMED) today announced Professor Anthony J. Costello, M.D., Head of the Department of Urology of the Royal Melbourne Hospital of the University of Melbourne (Australia), will serve as Lead Investigator in Asia and Southeast Asia, subject to their receiving funding, of the three (3), 300 patient, randomized, controlled clinical trials of Urodyne, Inc. ("Urodyne") in the treatment of Benign Pro
LAKE FOREST, CA — (Marketwire) — 12/21/12 — TRIMEDYNE, INC. ("Trimedyne") (OTCBB: TMED), today announced Graham M. Watson, M.D., has agreed to serve as Lead Investigator in Europe and the Middle East, subject to receiving funding, of the three (3), 300 patient, randomized clinical trials of Urodyne, Inc. ("Urodyne") to treat Benign Prostatic Hyperplasia or BPH, commonly referred to as an "Enlarged Prostate," urinary incontinence and fecal incontinence in Endosco
GUELPH, ONTARIO — (Marketwire) — 12/21/12 — Armtec Infrastructure Inc. (TSX: ARF)(TSX: ARF.DB) today reported that its operating subsidiary, Armtec Holdings Limited ("Armtec" or the "Company") has completed a refinancing of its senior secured loan facility with a Brookfield Asset Management Company ("Existing Facility"). The new refinancing arrangement comprises a $60 million revolving asset based loan with Canadian Imperial Bank of Commerce and a $110 million
MONTREAL, QUEBEC — (Marketwire) — 12/20/12 — Velan Inc. (TSX: VLN) today announced that on Tuesday, January 8, 2013, it will release third quarter results ended November 30, 2012.The company will hold an analyst call on Tuesday, January 8, 2013 at 4:30 p.m. (Eastern Daylight Time) to discuss the results. The call may be accessed by dialing 888-224-7971, and quoting the reservation number 21628978. There will be a PostView available for 7 days following this conference call. The numbers are
LAKE FOREST, CA — (Marketwire) — 12/20/12 — TRIMEDYNE, INC. ("Trimedyne") (OTCBB: TMED) today announced that Robert S. Cowles, III, M.D. has agreed to serve as Co-Chairman with Dr. Marvin P. Loeb of the Boards of Directors and as Medical Director of Urodyne, Inc. ("Urodyne") and Hyperdyne, Inc. ("Hyperdyne"), two subsidiaries Trimedyne plans to organize. (See Trimedyne-s Press Release of November 28, 2012).Dr. Cowles will be the Chief Investigator of, and subjec
There is a catalogue with more than 630 different lots available. One of the largest lighter collections in Southern Germany is on auction sale now!
VANCOUVER, BRITISH COLUMBIA and LISLE, ILLINOIS — (Marketwire) — 12/18/12 — Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -The Company reports that it is currently changing its fiscal year end to December 31 effective December 31, 2012. The Company will prepare year end financial statements for the four month period ended December 31, 2012 to complete the transition. The change is being implemented to align the Company-s business cyc
